Related references
Note: Only part of the references are listed.Combining systemic and locally applied cellular therapies for the treatment of systemic sclerosis
Melanie Velier et al.
BONE MARROW TRANSPLANTATION (2022)
Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party
Joerg Henes et al.
HAEMATOLOGICA (2021)
Cardiac safe hematopoietic stem cell transplantation for systemic sclerosis with poor cardiac function: a pilot safety study that decreases neutropenic interval to 5 days
Richard K. Burt et al.
BONE MARROW TRANSPLANTATION (2021)
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial
Satoshi Ebata et al.
LANCET RHEUMATOLOGY (2021)
Effect of mycophenolate mofetil (MMF) on systemic sclerosis-related interstitial lung disease with mildly impaired lung function: a double-blind, placebo-controlled, randomized trial
G. S. R. S. N. K. Naidu et al.
RHEUMATOLOGY INTERNATIONAL (2020)
Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study
Sandra van Bijnen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantation
Michael Gernert et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Perrine Guillaume-Jugnot et al.
CLINICAL RHEUMATOLOGY (2019)
CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan
Masahiro Ayano et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Determinants of mortality in systemic sclerosis: a focused review
Dilli Ram Poudel et al.
RHEUMATOLOGY INTERNATIONAL (2018)
Autologous Hematopoietic Stern Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis
Roni Shouval et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Autologous haematopoietic stem cell transplantation for Japanese patients with systemic sclerosis: Long-term follow-up on a phase II trial and treatment-related fatal cardiomyopathy
Hiroyuki Nakamura et al.
MODERN RHEUMATOLOGY (2018)
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
K. M. Sullivan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis
Grzegorz Helbig et al.
CLINICAL RHEUMATOLOGY (2018)
Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients
Lucas C. M. Arruda et al.
BLOOD ADVANCES (2018)
Update of EULAR recommendations for the treatment of systemic sclerosis
Otylia Kowal-Bielecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis
N. Del Papa et al.
BONE MARROW TRANSPLANTATION (2017)
Cardiovascular magnetic resonance in systemic sclerosis: Pearls and pitfalls
Sophie I. Mavrogeni et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease An Analysis of Scleroderma Lung Studies I and II
Elizabeth R. Volkmann et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases
John A. Snowden et al.
BLOOD ADVANCES (2017)
Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners
D. Farge et al.
BONE MARROW TRANSPLANTATION (2017)
Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells
Eveline M. Delemarre et al.
BLOOD (2016)
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P. Tashkin et al.
LANCET RESPIRATORY MEDICINE (2016)
Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014
Amber Young et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study
J. Baraut et al.
BONE MARROW TRANSPLANTATION (2014)
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis A Randomized Clinical Trial
Jacob M. van Laar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Therapeutic angiogenesis in patients with systemic sclerosis by autologous transplantation of bone-marrow-derived cells
Yoshiaki Ishigatsubo et al.
Modern Rheumatology (2014)
Autologous stem cell transplantation with thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestations
Joerg C. Henes et al.
RHEUMATOLOGY (2014)
Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis
Richard K. Burt et al.
LANCET (2013)
Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation
J. A. Snowden et al.
BONE MARROW TRANSPLANTATION (2012)
Optimization of Autologous Stem Cell Transplantation for Systemic Sclerosis - A Single-center Longterm Experience in 26 Patients with Severe Organ Manifestations
Joerg C. Henes et al.
JOURNAL OF RHEUMATOLOGY (2012)
Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies
Muriel Elhai et al.
RHEUMATOLOGY (2012)
Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma
Robyn T. Domsic et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Predicting Treatment Outcomes and Responder Subsets in Scleroderma-Related Interstitial Lung Disease
Michael D. Roth et al.
ARTHRITIS AND RHEUMATISM (2011)
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial
Richard K. Burt et al.
LANCET (2011)
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Anthony J. Tyndall et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis
M. C. Vonk et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Effects of 1-year treatment with CycNophosphamilde on outcomes at 2 years in scleroderma lung disease
Donald P. Tashkin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis
Y. Oyama et al.
BONE MARROW TRANSPLANTATION (2007)
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study
Richard A. Nash et al.
BLOOD (2007)
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
Rachel K. Hoyles et al.
ARTHRITIS AND RHEUMATISM (2006)
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Autologous stem cell transplantation in the treatment of systemic sclerosis:: report from the EBMT/EULAR Registry
D Farge et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study
D Farge et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
